Wedbush Issues Optimistic Outlook for MLTX Earnings
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Stock analysts at Wedbush increased their Q2 2025 earnings per share (EPS) estimates for shares of MoonLake Immunotherapeutics in a research report issued to clients and investors on Tuesday, May 13th. Wedbush analyst Y. Zhong now forecasts that the company will earn ($0.70) per share for the quarter, […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Stock analysts at Wedbush increased their Q2 2025 earnings per share (EPS) estimates for shares of MoonLake Immunotherapeutics in a research report issued to clients and investors on Tuesday, May 13th. Wedbush analyst Y. Zhong now forecasts that the company will earn ($0.70) per share for the quarter, […]
